On Day 1 of his second term of office, Trump rescinded Biden's Executive Order 14087, "Lowering Prescription Drug Costs for ...

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...

The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage (MA) ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

The landscape of home health care is evolving through the introduction of two key models designed to improve patient outcomes ...

Federal health agencies, including the Centers for Medicare & Medicaid Services, have halted their communication efforts in ...

Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...

Trump reversed former President Joe Biden's order on "Lowering Prescription Drug Costs for Americans" on Monday.

In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

As a primer from technology company MDInteractive explains it, “CMS implemented a multi-year transition from 2021 to 2024 for MSSP ACOs to move from reporting quality data through the CMS Web ...